Merck & Co (MRK) EBITDA margin US GAAP (year values) |
|||||||||
| 2023 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 11.4% | 11.5% | 11.5% | 40.1% | 45.2% | 34.6% | ||
| Changes by years, y/y, % | -25pp | +0pp | 0pp | +29pp | +5pp | +13.0% | |||
Merck & Co. EBITDA margin, %
Merck & Co. EBITDA margin, changes, pp
Merck & Co (MRK) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 50.0% | 46.9% | 49.7% | 52.8% | -11.6% | 34.6% | |
| Changes by years, y/y, % | +6pp | +1pp | +16pp | +16pp | -62pp | |||
| Changes by quarters, q/q, % | +14pp | -3pp | +3pp | +3pp | -64pp | |||